AAAAAA
Results: 1-25/28
Authors:
Hecht, N
Pappo, O
Shouval, D
Rose-John, S
Galun, E
Axelrod, JH
Citation: N. Hecht et al., Hyper-IL-6 gene therapy reverses fulminant hepatic failure, MOL THER, 3(5), 2001, pp. 683-687
Authors:
Granot, E
Shouval, D
Ashur, Y
Citation: E. Granot et al., Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients, MEDIAT INFL, 10(5), 2001, pp. 253-258
Authors:
Safadi, R
Or, R
Ilan, Y
Naparstek, E
Nagler, A
Klein, A
Ketzinel-Gilaad, M
Ergunay, K
Danon, D
Shouval, D
Galun, E
Citation: R. Safadi et al., Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation, BONE MAR TR, 27(2), 2001, pp. 183-190
Authors:
Ginsberg, GM
Slater, PE
Shouval, D
Citation: Gm. Ginsberg et al., Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity, J HEPATOL, 34(1), 2001, pp. 92-99
Authors:
Shapira, MY
Zeira, E
Adler, R
Shouval, D
Citation: My. Shapira et al., Rapid seroprotection against hepatitis B following the first dose of a Pre-S-1/Pre-S-2/S vaccine, J HEPATOL, 34(1), 2001, pp. 123-127
Authors:
Durand, F
Bernuau, J
Giostra, E
Mentha, G
Shouval, D
Degott, C
Benhamou, JP
Valla, D
Citation: F. Durand et al., Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine, GUT, 48(6), 2001, pp. 849-852
Authors:
Ketzinel-Gilad, M
Colodner, SL
Hadary, R
Granot, E
Shouval, D
Galun, E
Citation: M. Ketzinel-gilad et al., Transient transmission of hepatitis C virus from mothers to newborns, EUR J CL M, 19(4), 2000, pp. 267-274
Authors:
Peters, MG
Shouval, D
Bonham, A
Vierling, JM
Lok, ASF
Citation: Mg. Peters et al., Posttransplantation: Future therapies, SEM LIV DIS, 20, 2000, pp. 19-24
Authors:
Shouval, D
Samuel, D
Citation: D. Shouval et D. Samuel, Hepatitis B immune globulin to prevent hepatitis B virus graft reinfectionfollowing liver transplantation: A concise review, HEPATOLOGY, 32(6), 2000, pp. 1189-1195
Authors:
Eren, R
Ilan, E
Nussbaum, O
Lubin, I
Terkieltaub, D
Arazi, Y
Ben-Moshe, O
Kitchinzky, A
Berr, S
Gopher, J
Zauberman, A
Galun, E
Shouval, D
Daudi, N
Eid, A
Jurim, O
Magnius, LO
Hammas, B
Reisner, Y
Dagan, S
Citation: R. Eren et al., Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-Trimera mouse model and in HBV chronic carrier chimpanzees, HEPATOLOGY, 32(3), 2000, pp. 588-596
Authors:
Bocher, WO
Galun, E
Marcus, H
Daudi, N
Terkieltaub, D
Shouval, D
Lohr, HF
Reisner, Y
Citation: Wo. Bocher et al., Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse, HEPATOLOGY, 31(2), 2000, pp. 480-487
Authors:
Ilan, Y
Nagler, A
Zeira, E
Adler, R
Slavin, S
Shouval, D
Citation: Y. Ilan et al., Maintenance of immune memory to the hepatitis B envelope protein followingadoptive transfer of immunity in bone marrow transplant recipients, BONE MAR TR, 26(6), 2000, pp. 633-638
Authors:
Shouval, D
Citation: D. Shouval, Is universal vaccination against hepatitis B sufficient for control of HBVinfection? Lessons from the immunization campaign in Italy, J HEPATOL, 33(6), 2000, pp. 1009-1011
Authors:
Hirshberg, B
Shouval, D
Fibach, E
Friedman, G
Ben-Yehuda, D
Citation: B. Hirshberg et al., Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chiari syndrome, J HEPATOL, 32(4), 2000, pp. 574-578
Authors:
Safadi, R
Ergunay, K
Ilan, Y
Klein, A
Shouval, D
Manny, N
Harush, N
Galun, E
Citation: R. Safadi et al., TT virus infection in Israeli patients with fulminant hepatic failure, VOX SANGUIN, 79(4), 2000, pp. 242-245
Authors:
Galun, E
Nahor, G
Eid, A
Jurim, O
Rose-John, S
Blum, HE
Nussbaum, O
Ilan, E
Daudi, N
Shouval, D
Reisner, Y
Dagan, S
Citation: E. Galun et al., Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo, VIROLOGY, 270(2), 2000, pp. 299-309
Authors:
Frey, S
Dagan, R
Ashur, Y
Chen, XQ
Ibarra, J
Kollaritsch, H
Mazur, MH
Poland, GA
Reisinger, K
Walter, E
Van Damme, P
Braconier, JH
Uhnoo, I
Wahl, M
Blatter, MM
Clements, D
Greenberg, D
Jacobson, RM
Norrby, SR
Rowe, M
Shouval, D
Simmons, SS
van Hattum, J
Wennerholm, S
Gress, JO
Chan, I
Kuter, B
Citation: S. Frey et al., Antibody production in response to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine - Reply, J INFEC DIS, 182(3), 2000, pp. 1005-1006
Authors:
Sebagh, M
Debette, M
Samuel, D
Emile, JF
Falissard, B
Cailliez, V
Shouval, D
Bismuth, H
Reynes, M
Citation: M. Sebagh et al., "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection, HEPATOLOGY, 30(5), 1999, pp. 1144-1150
Authors:
Adler, R
Safadi, R
Caraco, Y
Rowe, M
Etzioni, A
Ashur, Y
Shouval, D
Citation: R. Adler et al., Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation, HEPATOLOGY, 29(4), 1999, pp. 1299-1305
Authors:
Ilan, E
Burakova, T
Dagan, S
Nussbaum, O
Lubin, I
Eren, R
Ben-Moshe, O
Arazi, J
Berr, S
Neville, L
Yuen, L
Mansour, TS
Gillard, J
Eid, A
Jurim, O
Shouval, D
Reisner, Y
Galun, E
Citation: E. Ilan et al., The hepatitis B virus-trimera mouse: A model for human HBV infection and evaluation of Anti-HBV therapeutic agents, HEPATOLOGY, 29(2), 1999, pp. 553-562
Authors:
Ashur, Y
Adler, R
Rowe, M
Shouval, D
Citation: Y. Ashur et al., Comparison of immunogenicity of two hepatitis A vaccines - VAQTA (R) and HAVRIX (R) - in young adults, VACCINE, 17(18), 1999, pp. 2290-2296
Authors:
Marcellin, P
Alberti, A
Dusheiko, G
Esteban, R
Manns, M
Shouval, D
Weiland, O
Williams, R
Benhamou, JP
Rodes, J
Alter, H
Bismuth, H
Desmet, V
Guardia, J
Heathcote, J
Lok, A
Maddrey, WC
Zum Buschenfelde, KHM
Pagliaro, L
Paumgartner, G
Sherlock, S
Abrignani, S
Alberti, A
Alter, M
Bonino, F
Bortolotti, F
Brechot, C
de Moura, MC
Carreno, V
Colombo, M
Craxi, A
Davis, G
De Francesco, R
Degos, F
Di Bisceglie, A
Dienes, H
Dusheiko, G
Esteban, J
Esteban, R
Farci, P
Ferrari, C
Foster, G
Hadziyannis, S
Hoofnagle, J
Koff, R
Lavanchy, D
Lindsay, K
Lunel, F
Manns, M
Marcellin, P
Mondelli, M
Nalpas, B
Naoumov, N
Pawlotsky, JM
Pol, S
Pontisso, P
Poynard, T
Prieto, J
Rizzetto, M
Roggendorf, M
Moreno, MR
Samuel, D
Sanchez-Tapias, J
Schalm, S
Shouval, D
Simmonds, P
Soriano, V
Tassopoulos, N
Thomas, H
Trepo, C
Van der Poel, CL
Vogel, W
Weiland, O
Wejstal, R
Williams, R
Wright, T
Zanetti, A
Zarski, JP
Zeuzem, S
Zoulim, F
Citation: P. Marcellin et al., EASL International Consensus Conference on Hepatitis C - Paris, 26-27 February 1999 - Consensus statement (Reprinted from Journal of Hematology, vol 30, pg 956-961, 1999), J HEPATOL, 31, 1999, pp. 3-8
Authors:
Shouval, D
Ashur, Y
Citation: D. Shouval et Y. Ashur, Hepatitis A vaccine for secondary hepatitis A infection, LANCET, 354(9175), 1999, pp. 342-342
Authors:
Safadi, R
Eid, A
Ilan, Y
Goldin, E
Shouval, D
Wengrower, D
Blanchar, A
Libbson, E
Verstandig, A
Ashur, Y
Jurim, O
Citation: R. Safadi et al., The role of ERCP in biliary complications after liver transplantation, TRANSPLAN P, 31(4), 1999, pp. 1897-1898
Authors:
Frey, S
Dagan, R
Ashur, Y
Chen, XQ
Ibarra, J
Kollaritsch, H
Mazur, MH
Poland, GA
Reisinger, K
Waiter, E
Van Damme, P
Braconier, JH
Uhnoo, I
Wahl, M
Blatter, MM
Clements, D
Greenberg, D
Jacobson, RM
Norrby, SR
Rowe, M
Shouval, D
Simmons, SS
van Hattum, J
Wennerholm, S
Gress, JO
Chan, I
Kuter, B
Citation: S. Frey et al., Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine, J INFEC DIS, 180(6), 1999, pp. 2018-2022